All Insights Articles
The Funding Crisis Facing Nonprofits
We talked to Andrea Levere ’83 and Alexandra Sing ’20, CEO and COO of Capitalize Good, about the state of the social sector and the increased urgency of their work working with funders and nonprofits to move toward a model of stable, long-term capital.
Has Inflation Been Tamed?
We asked Prof. William English to explain the Fed’s approach to interest rates and the potential consequences of tariffs and budget cuts.
CEOs Don’t Want to Return to Russia, Because They Know It’s Bad Business
Amid warming relations with Washington, Vladimir Putin is floating new opportunities for Western companies in Russia. But Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian write that business leaders are reluctant to reengage in a dangerous setting and a faltering economy.
Do Oscar Wins Pay Off?
We asked Prof. Abraham Ravid, who studies the economics of the film business, to break down the financial stakes of Hollywood’s biggest night.
Elon Musk Is Kicking Down the Barn, Not Building a Better Government
Yale SOM leadership expert Jeffrey Sonnenfeld writes that rather than zeroing in on waste and bureaucracy, the Department of Government Efficiency is driving out thousands of critical workers.
A Simple Thumbs Up or Down Eliminates Racial Bias in Online Ratings
Yale SOM’s Tristan Botelho and his co-authors found that the ubiquitous five-star rating system could subtly propagate discrimination. But they also found a surprisingly simple fix: switching to a two-point scale (thumbs up or thumbs down) eliminated subtle racial bias in customer ratings of gig workers.
Are Trump’s Tariffs Repairing Market Failures or Eroding Global Trust?
Yale SOM’s Jeffrey Sonnenfeld and co-authors Stephen Henriques and Steven Tian write that while there are legitimate reasons for some tariffs, the president’s arbitrary approach is worrying allies and unsettling markets.
Does the Rasputin Curse Live Again?
Leadership expert Jeffrey Sonnenfeld and co-author Steven Tian look across history for examples of pitfalls that could lie ahead for Elon Musk and Donald Trump.
The Consequences of Slashing Medicaid Spending
Congressional Republicans are looking to make deep budget cuts, and Medicaid spending is a target. Yale SOM’s Dr. Howard Forman says that large-scale reductions in the program would hit the poorest states and the most vulnerable Americans especially hard.
What Investors Are Missing about Pfizer and Merck
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey Sonnenfeld and co-author Steven Tian.